Reports 2 Feb 2026Adopting AI in biologics discovery Learn about current challenges and the future of adopting AI in biologics discovery. February 2, 2026 Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 Jan 2026 Seven Italian biotechs to know about in 2026 Delve into Italy’s biotech landscape with seven companies that are leading the charge in the European country. January 28, 2026 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 27 Jan 2026 How the University of North Carolina at Chapel Hill is enhancing RNAi potency with its new technology Discover how a newly developed platform technology from The University of North Carolina at Chapel Hill can enhance RNAi potency. January 27, 2026 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 26 Jan 2026 A clearer path to relief: sinusitis treatments on the way Emerging sinusitis treatments include monoclonal antibodies to tackle the unmet medical needs of patients. January 26, 2026 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Webinars Produced by Inpart 26 Jan 2026Partnering trends and predictions 2026 A data-driven discussion on biopharma partnering trends, exploring dealmaking signals, AI-driven collaboration, and new approaches to R&D and BD landscaping shaping 2026. January 26, 2026 Share WhatsApp Twitter Linkedin Email Produced by Inpart
In Depth 23 Jan 2026 What does 2026 hold for the biotech industry? Delve into what 2026 has to offer in the biotech industry. The market is showing signs it’s picking up and the patent cliff is driving deals. January 23, 2026 - 11 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Podcast 23 Jan 2026Top 5 trends that will drive biopharma in the next decade with Tim Opler Today, we’re thrilled to have Tim Opler, a leading voice in biotech investment banking. January 23, 2026 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 21 Jan 2026 Could CRISPR really cure these diseases? Here are some of the diseases that scientists aim to tackle using CRISPR technology, testing its possibilities and limits as a medical tool. January 21, 2026 - 16 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 20 Jan 2026 Hepatitis B: Are we edging closer to a cure? Find out whether we are closing in on a cure for hepatitis B – a virus affecting the liver that can cause acute and chronic disease. January 20, 2026 - 10 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Sponsored by WittKieffer 20 Jan 2026 From science to scale: building biotech companies via milestone leadership Explore how leadership in biotech drives success through a milestone approach, aligning teams and culture from science to scale. January 20, 2026 - 10 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Best in Biotech 19 Jan 2026 Curing ALS? Ten companies developing new treatments in 2026 Delve into the increasingly dynamic landscape of ALS treatment development with ten companies advancing candidates in 2026. January 19, 2026 - 12 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Whitepapers 19 Jan 2026Robust lentiviral manufacturing platforms in the age of accessible cell therapy Discover how lentiviral platforms and ready-to-deploy CAR-T solutions are overcoming barriers of global access to life-saving cures. January 19, 2026 Share WhatsApp Twitter Linkedin Email
In Depth 25 Jan 2024The trends that will shape the biotech industry in 2024 What does 2024 hold for the biotech industry? Delve into the experts’ insight on the biotech trends that will shape 2024. January 25, 2024 - 13 minutesmins - By Jules Adam Share WhatsApp Twitter LinkedIn Email
Best in Biotech 3 Jan 2024The top-performing countries in biotechnology (according to the OECD) Explore the OECD’s top-performing countries for biotech, from the U.S. powerhouse to the promising landscapes of the U.K., Belgium, and more. January 3, 2024 - 14 minutesmins - By Jules Adam Share WhatsApp Twitter LinkedIn Email
Podcast 19 Jan 2024Epigenetic editing – the power of CRISPR without cutting DNA Epic Bio is an epigenetic editing company, leveraging the power of CRISPR without cutting DNA. The company’s proprietary Gene Expression Modulation System (GEMS) includes the smallest Cas protein known to work in human cells. This enables in vivo or ex vivo delivery via a single viral vector. Epic’s lead program, EPI-321, is in IND-enabling studies […] January 19, 2024 - 6 minutesmins - By Jim Cornall Share WhatsApp Twitter LinkedIn Email
Best in Biotech 12 Apr 20246 biotechnology universities in the US nurturing tomorrow’s trailblazers Discover the top biotechnology universities in the US offering cutting-edge programs that are helping students find a career in biotech. April 12, 2024 - 12 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter LinkedIn Email
In Depth 9 Feb 2024Biotech job market 2024: what to expect? The past year saw pipeline cuts and downsizing plans strike the biotech industry. Does the biotech job market seem to be looking up this year? February 9, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter LinkedIn Email
Expert Advice 15 Mar 2024Is biotechnology a good career? Here are the pros and cons Find out about the pros and cons of pursuing a career in biotechnology, from competitive salaries to dealing with regulatory hurdles. March 15, 2024 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter LinkedIn Email
In Depth 8 Jul 2024Bridge RNA: A new gene editing technique that could overcome the limitations of CRISPR Find out how the recent discovery of a molecular oddity found in bacteria has led to a new gene editing technique. July 8, 2024 - 5 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter LinkedIn Email
Best in Biotech 27 Mar 202512 AI drug discovery companies you should know about Take a look at 12 of the top AI drug discovery companies around today, using their technology to speed up the drug discovery process. March 27, 2025 - 19 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter LinkedIn Email
In Depth 12 Feb 2024RNA editing set to take off: could DNA’s short-lived cousin overcome the limitations of CRISPR gene editing? Find out all about about RNA editing, as two candidates have just managed to reach the clinic for the first time. February 12, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter LinkedIn Email
Expert Advice 12 Sep 2025Eight biotech career paths where demand is skyrocketing Check out eight important biotechnology careers that are currently in high demand, and likely still will be in the coming years. September 12, 2025 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter LinkedIn Email
Best in Biotech 16 Dec 202410 biotech companies to watch in 2025 As 2025 is expected to be an exciting year for the biopharma industry, discover ten biotech companies to keep an eye on in 2025. December 16, 2024 - 14 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter LinkedIn Email
Best in Biotech 13 Mar 2025Nine biotechs thriving in Seattle in 2025 In this article, let us take a look at some of the major biotech companies in Seattle that are contributing to the biotech industry at large. March 13, 2025 - 12 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter LinkedIn Email
